Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography-guided stereotactic biopsy

Cancer

Volumn 78, Issue 5, 1996, Pages 1098-1106

  Goldman, Serge ^a   Levivier, Marc ^a   Pirotte, Benoît ^a   Brucher, Jean Marie ^b   Wikler, David ^a   Damhaut, Philippe ^a   Stanus, Etienne ^a   Brotchi, Jacques ^a   Hildebrand, Jerzy ^a  

^a ERASME HOSPITAL   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

brain; brain biopsy; brain neoplasm; fluorodeoxyglucose; glioma; glucose metabolism; neuropathology; positron emission tomography; stereotaxy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; STEREOTAXIS;

ADULT; AGED; BIOPSY; BLOOD GLUCOSE; BRAIN NEOPLASMS; CHI-SQUARE DISTRIBUTION; GLIOMA; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029794245     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960901)78:5<1098::AID-CNCR21>3.0.CO;2-X     Document Type: Article

References (50)

1. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-9.
2. Di Chiro G, Brooks RA, Patronas NJ, Bairamian D, Kornblith PL, Smith BH, et al. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 1984;15:S138-46.
3. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-22.
4. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988;62:1074-8.
5. Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 1987;22:360-71.
6. Francavilla TL, Miletich RS, Di Chiro G, Patronas NJ, Rizzoli HV, Wright DC. Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 1989;24:1-5.
7. Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, et al. Identification of early recurrence of primary central nervous system tumors by [18F] fluorodeoxyglucose positron emission tomography. Ann Neurol 1991;29:347-55.
8. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 1991;10:85-91.
9. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-22.
10. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47-52.
11. Paulus W, Peiffer J. Intratumoral histologic heterogeneity of gliomas: a quantitative study. Cancer 1989;64:442-7.
12. Russel DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th edition. London: Arnold, 1989.
13. Paul R, Johansson R, Kellokumpu-Lehtinen PL, Soderström KO, Kangas L. Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat. Res Exp Med (Berl) 1985;185:87-94.
14. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988;61:1776-81.
15. Warburg O. The metabolism of tumors. London: Arnold Constable, 1930:75-327.
16. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
17. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of (fluorine-18)fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiography study. J Nucl Med 1994;35:1067-75.
18. Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-92.
19. Levivier M, Goldman S, Bidaut LM, Luxen A, Stanus E, Przedborski S, et al. Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 1992;31:792-7.
20. Levivier M, Goldman S, Pirotte B, Brucher J, Balériaux D, Luxen A, et al. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with (18F)-fluorodeoxyglucose. J Neurosurg 1995;82:445-52.
21. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. 2nd edition. Berlin: Springer-Verlag, 1993:1-37.
22. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-8.
23. Messa C, Choi Y, Hoh CK, Jacobs EL, Glaspy JA, Rege S, et al. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr 1992;16:684-9.
24. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
25. Phelps ME, Huang SC, Hoffman EH, Selin C, Sokoloff L, Kuhl D. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-88.
26. Herholz K, Rudolf J, Heiss WD. FDG transport and phosphorylation in human gliomas measured with dynamic PET. J Neurooncol 1992;12:159-65.
27. Herholz K, Pietrzyk U, Voges J, Schroder R, Halber M, Treuer H, et al. Correlation of glucose consumption and tumor cell density in astrocytomas - a stereotactic PET study. J Neurosurg 1993;79:853-8.
28. De Witte O, Hildebrand J, Luxen A, Goldman S. Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 1994;74:2836-42.
29. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-based stereotactic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987; 66:865-74.
30. Brucher J-M. Neuropathological diagnosis with stereotactic biopsies. Possibilities, difficulties and requirements. Acta Neurochir (Wien) 1993;124:37-9.
31. Sachs L. Applied statistics. A handbook of techniques. 2nd edition. New York: Springer-Verlag, 1984:462-74.
32. Goldman S, Dewitte O, Levivier M, Violon P, Damhaut P, Wilder D, et al. Glucose uptake in glioma: relationship to local histology and prognostic value in low grade tumor [abstract]. Proceedings of the Eleventh International Conference on Brain Tumor Research and Therapy, Napa, California, October 31-November 3, 1995.
33. Junck L, McKeever PE, Ross DA, Greenberg HS, Brunberg JA, Betley AT. The significance of fluorodeoxyglucose uptake in gliomas [abstract]. J Cereb Blood Flow Metab 1995; 15:S737.
34. Bergström M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 1983;7:1062-6.
35. Hanson MW, Glantz MJ, Hoffman JM, Friedman AH, Burger PC, Schold SC, et al. FDG-PET in the selection of brain lesions for biopsy. J Comput Assist Tomogr 1991;15:796-801.
36. Thomas DGT, Gill SS, Wilson C. Current and future utilization of PET scanning in the evaluation and management of malignant cerebral glioma. In: Appuzzo MLJ, editor. Malignant cerebral glioma. Park Ridge, III: American Association of Neurological Surgeons, 1991:79-89.
37. Mosskin M, von-Holst H, Bergstrom M, Collins VP, Eriksson L, Johnstrom P, et al. Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 1987;28:673-81.
38. Maciunas RJ, Kessler RM, Maurer C, Mandava V, Watt G, Smith G. Positron emission tomography imaging-directed stereotactic neurosurgery. Stereotact Funct Neurosurg 1992; 58:134-40.
39. Daumas-Duport C, Scheithauer BW, O'Fallon J, Kelly PJ. Grading of astrocytomas: a simple and reproductible method. Cancer 1988;62:2152-65.
40. Black KL. Brain tumors (2 parts). N Engl J Med 1991; 324:1471-6, 1555-64.
41. Hildebrand J, Delecluse F. Malignant glioma. In: Slavin ML, Staquet MJ, editors. Randomized trials in cancer. New York: Raven Press, 1986:583-604.
42. Mineura K, Sasajima T, Kowada H, Ogawa T, Hatazawa J, Shishido F, et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994;73:2386-94.
43. Yamamoto T, Seino Y, Fukomoto H, Koh G, Yano H, Inagchi N, et al. Over-expression of facilitate glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990;170:223-30.
44. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of Fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
45. 18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr 1990;14:486-7.
46. Hoffman JM, Waskin HA, Schifter T, Hanson MW, Gray L, Rosenfeld S, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993;34:567-75.
47. 18F]Fluorodeoxyglucose PET study in brain hematoma. J Nucl Med 1994;35:1162-6.
48. Dethy S, Manto M, Kentos A, Konopnicki D, Pirotte B, Goldman S, et al. PET findings in a brain abscess associated with a silent atrial septal defect. Clin Neurol Neurosurg 1995; 97:349-53.
49. Hino A, Imahori Y, Tenjin H, Mizukawa N, Ueda S, Hirakawa K, et al. Metabolic and hemodynamic aspects of peritumoral low-density areas in human brain tumor. Neurosurgery 1990;26:615-21.
50. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.